Positive ARTISTRY-2 Trial Results for BIC LEN H...

By HEOR Staff Writer

December 17, 2025

BIC/LEN HIV Regimen Delivers Non-Inferior Results in ARTISTRY-2 Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial, demonstrating that ...
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Antidepressant Side Effects: New Insights on Cardiometabolic Health Risks
Obesity Health Economics: Forecasting Trends and Costs in the US
AI Chatbot Delusions: Navigating the Risks of Validation in Mental Health
Colorectal Cancer Markers: Discovering Region-Specific Drivers for Precision ...